FISV has fallen from above $230 to approximately $54.50, erasing roughly three-quarters of its value in little more than a year.

At first glance, the setup looks exceptional: the Master Buy Scanner V2 gives Fiserv a maximum 3/3 technical score, a near-maximum valuation score and a maximum growth score.

But the scanner’s final verdict remains unambiguous:

NO BUY — WAIT.

The stock is inexpensive and increasingly oversold, but the monthly reversal conditions have not yet been completed.

Master Buy Scanner V2 — Monthly
Score: 3/3
Signal timeframe: 1M → 1M / 3W
Timeframe confidence: 1M OK
Action: WAIT
Decision: WAIT
BUY state: NO EVENT
Entry quality: GOOD — 75%
Setup maturity: LATE
Position size: NONE — 0%
Top recent: SOFT
WT cross: TURNING — not confirmed
Band 1: GREEN
Combined band: GREEN 6/10
Bands synchronized: YES
Cycle: NO
Bars since previous BUY: 206
WT1 / WT2: approximately -37.5 / -36.0

The technical picture is improving, but it is incomplete.

Band 1 is green, the lower bands are synchronized and the combined reading has reached 6/10. However, the WT cross has not been properly confirmed, the cycle has not fired and there is no formal BUY event.

The setup is also classified as LATE, suggesting that the current configuration does not offer the clean early-cycle alignment seen in stronger monthly signals.

This is why the scanner assigns 0% position size, despite the attractive entry-quality score.

The collapse reflects a real deterioration in results

Fiserv’s first-quarter 2026 results were materially weaker than the company’s historical performance.

GAAP revenue declined 2%
Organic revenue declined 4%
Adjusted EPS declined 16%
Adjusted operating margin fell from 37.8% to 29.7%
Free cash flow declined from $371 million to $259 million

Both major segments experienced substantial margin compression. Merchant Solutions’ operating margin fell from 34.2% to 26.4%, while Financial Solutions declined from 47.5% to 38.1%.

The deterioration was driven by lower high-margin data and analytics revenue, weaker licence sales, increased personnel and data-processing costs, higher payments to distribution partners and spending associated with the One Fiserv transformation programme.

This is not simply a case of market sentiment turning negative while fundamentals remain unchanged. Fiserv is currently experiencing slower growth, falling profitability and elevated transformation costs.

Clover remains the most important asset

The strongest part of the thesis remains Clover, Fiserv’s payments and business-management platform for small and medium-sized merchants.

During Q1 2026, Clover gross payment volume increased 12% excluding a gateway conversion, while reported GPV grew 9%. Value-added-services revenue increased 18%, with penetration reaching 27%.

However, reported Clover revenue grew only 6%, as weaker hardware and data-and-analytics revenue created an approximately nine-percentage-point headwind.

This distinction is important.

Underlying payment activity remains relatively resilient, but Fiserv is currently generating less high-margin incremental revenue from that activity than investors previously expected.

The longer-term thesis requires Clover to become more than a payment-processing product. Fiserv wants it to develop into a broader operating system offering software, working capital, savings products, vertical solutions and other value-added services.

At its 2026 Investor Day, management targeted medium-term Clover GPV growth of 15%–20% and revenue growth of 10%–15% for 2027–2029.

The turnaround plan is ambitious

The One Fiserv strategy focuses on improving client service, strengthening Clover, modernising the Financial Solutions portfolio, using AI to reduce operating costs and applying more disciplined capital allocation.

Management continues to guide for:

1%–3% organic revenue growth in 2026
$8.00–$8.30 adjusted EPS
Approximately 34% adjusted operating margin
Approximately 90% free-cash-flow conversion

For 2027–2029, Fiserv targets adjusted revenue growth of 4%–6%, a 37%+ adjusted operating margin and adjusted EPS above $12 by 2029. Management also expects more than 200 basis points of margin improvement from Project Elevate.

These targets imply meaningful upside if execution succeeds.

However, the market is clearly demanding proof. Fiserv must demonstrate that the Q1 deterioration represents a temporary reset rather than a permanent reduction in the quality and growth rate of the business.

The valuation is extremely attractive

The scanner awards Fiserv a 6.5/7 valuation score:

Cash yield: 14.28%
Business-price multiple: 6.95
Cash-flow multiple: 13.45
Earnings multiple: 9.26
Current profit per share: $5.89
Debt-to-equity: 1.12

At approximately $54.50, the shares also trade at less than seven times the midpoint of management’s 2026 adjusted-EPS guidance.

That valuation would be exceptionally low for a company capable of returning to mid-single-digit revenue growth, double-digit EPS growth and margins above 35%.

But the discount exists for a reason. Investors are questioning the reliability of management’s forecasts, the sustainability of Fiserv’s margins and the amount of investment required to modernise its products and operating infrastructure.

Business quality has weakened

The scanner still classifies business quality as green, but the underlying score is only 2/3:

Return on capital: 6.59% — ORANGE
Margin trend: -1.81% — ORANGE
Profitability measure: 13.17%
Cash-generation measure: 20.48%

Fiserv remains profitable and strongly cash-generative, but the negative margin trend prevents it from qualifying as an unquestioned quality compounder at present.

Debt also requires attention. The scanner flags the debt-to-profit relationship in orange, while management expects leverage around 3.0x in 2026 before moving toward a 2.5x–3.0x range over the medium term.

The investment case therefore depends not only on revenue recovering, but also on margins and cash flow improving sufficiently to support deleveraging and continued share repurchases.

Growth expectations remain surprisingly strong

The scanner gives Fiserv a maximum 4/4 growth score:

Future profit growth: 35.03%
Three-year profit growth: 17.53%
Three-year sales growth: 6.11%
Estimate trend: 0%

This creates a significant disconnect between valuation and expected earnings growth.

The market is effectively pricing in a much weaker outcome than the scanner’s growth inputs suggest. That could create substantial upside if estimates prove accurate—but it also means further estimate reductions remain one of the largest risks.

Advanced confirmation remains insufficient

The advanced section is only orange:

Advanced score: 8/14 — 57%
Lifecycle: READY
Conviction: C+ — 64%
False-bottom assessment: OK

The false-bottom assessment is encouraging, but the overall advanced score is not strong enough to override the absence of a formal monthly BUY event.

“READY” means the stock is approaching a potentially actionable configuration. It does not mean the reversal has already been validated.

Q2 earnings are the immediate catalyst

Fiserv is scheduled to release its second-quarter results before the market opens on August 6, 2026.

The report should provide critical information about:

Whether organic revenue is beginning to recover
Whether Clover’s underlying momentum remains intact
Whether the margin decline is stabilising
Progress on Project Elevate
Confidence in the $8.00–$8.30 EPS guidance
The timing of the expected second-half acceleration

With the monthly scanner still showing NO EVENT, front-running this report carries meaningful risk.

Key technical levels
Immediate support: $50–$53
Major downside support: $44–$47
First resistance: $60–$65
Initial recovery confirmation: $70–$75
Major resistance: $90–$100
Structural recovery zone: $115–$125
Higher resistance: $140–$150

Holding above approximately $50 would keep the developing bottom intact.

A monthly reclaim of $60–$65 would be the first constructive step, while a move above $70–$75, followed by a higher low, would provide much stronger evidence of a durable reversal.

A sustained monthly close below approximately $45 would materially weaken the current setup.

My classification: DEEP-VALUE WATCH — NO BUY YET

Fiserv currently offers:

A maximum 3/3 technical score
Good 75% entry quality
A 93% valuation score
A maximum growth score
Strong recurring payments infrastructure
Continued underlying Clover volume growth
Significant potential upside if margins recover

But the warnings remain decisive:

No formal BUY event
No fired cycle
No confirmed WT cross
Zero recommended position size
Falling revenue and earnings
Severe margin compression
Elevated transformation spending
Meaningful execution and leverage risk
Q2 earnings immediately ahead

The stock may ultimately prove to be exceptionally undervalued, but the scanner is correctly separating cheap from ready to buy.

Current verdict: WAIT.

What would you do?

A) Start a small position before earnings
B) Wait for the Q2 results and monthly confirmation
C) Wait for a recovery above $65

Master Buy Scanner V2:

This is not financial advice. A low valuation does not guarantee that a bottom has formed, particularly when revenue, margins and earnings are declining.